Ieq Capital LLC Makes New $941,000 Investment in IDEX Corporation $IEX

Ieq Capital LLC bought a new stake in shares of IDEX Corporation (NYSE:IEX) in the second quarter, HoldingsChannel reports. The institutional investor bought 4,148 shares of the industrial products company’s stock, valued at approximately $941,000.

Several other hedge funds have also made changes to their positions in IEX. Callan Family Office LLC bought a new stake in shares of IDEX in the second quarter valued at about $2,728,000. Heartland Advisors Inc. bought a new position in IDEX during the 2nd quarter worth about $6,065,000. OneAscent Investment Solutions LLC bought a new position in IDEX during the 2nd quarter worth about $232,000. Allworth Financial LP purchased a new position in IDEX during the 2nd quarter valued at about $164,000. Finally, B. Metzler seel. Sohn & Co. AG bought a new stake in shares of IDEX in the 2nd quarter valued at about $5,535,000. 97.96% of the stock is currently owned by hedge funds and other institutional investors.

More IDEX News

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks Research raised several EPS estimates, including forecasts for fiscal 2026, fiscal 2027, fiscal 2028, Q4 2026, Q1 2027, Q4 2027, Q1 2028 and Q2 2028. The fiscal 2028 estimate increased to $10.54 from $10.45, while the fiscal 2027 forecast rose to $9.26 from $9.21, signaling improving longer-term earnings expectations.
• Positive Sentiment: Analysts remain cautiously optimistic about IDEX’s prospects, and the company has outperformed the broader market over the past year. The latest consensus forecast calls for approximately $8.82 in current-year EPS, compared with the company’s guidance range of $8.70 to $8.85. Are Wall Street Analysts Predicting IDEX Stock Will Climb or Sink?
• Neutral Sentiment: The stock is trading near its 52-week high and above both its 50-day and 200-day moving averages, reflecting strong momentum. However, its price-to-earnings ratio of about 33.7 suggests investors are already paying a premium for expected growth, which may limit additional gains without further earnings upgrades.
• Negative Sentiment: Zacks Research slightly reduced its Q3 2026 EPS forecast to $2.19 from $2.20. Although the change is minor and remains close to the broader outlook, it provides a modest near-term headwind and may contribute to investor caution.

Wall Street Analyst Weigh In

IEX has been the subject of several research reports. TD Cowen upped their price target on shares of IDEX from $260.00 to $275.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Stifel Nicolaus boosted their price objective on shares of IDEX from $257.00 to $268.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Argus upped their target price on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Royal Bank Of Canada increased their target price on IDEX from $261.00 to $280.00 and gave the company an “outperform” rating in a research report on Thursday, July 30th. Finally, Robert W. Baird set a $257.00 price target on IDEX in a report on Thursday, April 30th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, IDEX presently has a consensus rating of “Moderate Buy” and an average price target of $260.80.

Insider Buying and Selling

In related news, CAO Lisa M. Anderson sold 385 shares of IDEX stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total value of $91,857.15. Following the completion of the sale, the chief accounting officer directly owned 4,327 shares in the company, valued at $1,032,378.93. This trade represents a 8.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.50% of the stock is owned by company insiders.

IDEX Stock Down 0.4%

Shares of IEX stock opened at $234.00 on Friday. The stock’s fifty day moving average price is $228.63 and its 200 day moving average price is $213.63. IDEX Corporation has a 1-year low of $158.19 and a 1-year high of $243.80. The company has a market cap of $17.25 billion, a price-to-earnings ratio of 33.67, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.05 and a quick ratio of 2.15.

IDEX (NYSE:IEX) last released its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. The company had revenue of $920.60 million during the quarter, compared to analysts’ expectations of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period last year, the business posted $2.07 earnings per share. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, research analysts expect that IDEX Corporation will post 8.82 earnings per share for the current fiscal year.

IDEX Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were given a $0.73 dividend. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend was Monday, July 6th. IDEX’s dividend payout ratio (DPR) is presently 42.01%.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.